Study of the effect of HFA-152a and HFA-134a propellants on mucociliary clearance in healthy participants

Trial Identifier:	221781
Sponsor:	GlaxoSmithKline
Start Date:	July 2024
Primary Completion Date:	October 2024
Study Completion Date:	October 2024
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Nottingham, United Kingdom, NG11 6JS

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.